Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study With [225Ac]Ac-FL-020 in mCRPC Participants
Phase 1
Recruiting
- Conditions
- Metastatic Castration-resistant Prostate Cancer
- Interventions
- Drug: [225Ac]Ac-FL-020Drug: Blood samples for PKDrug: [111In]In-FL-020Procedure: Blood and urine samples collectionProcedure: SPECT/CT images
- First Posted Date
- 2024-07-09
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- Full-Life Technologies GmbH
- Target Recruit Count
- 35
- Registration Number
- NCT06492122
- Locations
- 🇦🇺
MacQuarie University Clinical Trial Unit, Sydney, Australia
🇺🇸City of Hope Medical Center, Duarte, California, United States
🇺🇸University of Stanford, Stanford, California, United States
News
No news found